Saanroo Expands India Operations

Saanroo, the Austin, Texas-based ingredient supplier formerly known as Gencor's nutraceutical division, revealed that it is establishing go-to-market infrastructure in India, part of a wider effort to align its global commercial operations under the Saanroo name.¹

The expansion follows the company's October 2025 rebrand, when Gencor's nutraceutical business became Saanroo while Gencor Pacific continued operating as the separate pharmaceutical arm.

"This investment marks the next phase of Saanroo's global growth strategy," said John Quilter, Saanroo’s CEO. "By expanding our regional capabilities and deepening our presence in key markets, we're positioning the company for long-term growth and strengthening our ability to work more closely with customers and support the future of science-driven wellness."¹

What Is Driving Saanroo's Expansion Into India and Southwest Asia?

To lead the India expansion, Saanroo appointed Mukeshkumar Chauhan as deputy general manager for India and Southwest Asia.¹ Chauhan joins from Ashland, where he worked on establishing and scaling that company's film-coating business in India, and brings more than 15 years of sales, marketing, and business development experience across the pharmaceutical and nutraceutical industries. In his new role, Chauhan will lead commercial initiatives for Saanroo India, including customer relationships and strategic partnerships.¹

The India expansion follows 9 months of investment in Saanroo's North America and Latin America commercial footprint, with the company now shifting attention to the greater Asia Pacific region and Europe. Saanroo's commercial operations currently span North America, Europe, India, Vietnam, and Latin America under the unified brand.

How Does This Fit Into Broader Nutraceutical Market Trends in India?

India's nutraceutical market was valued at approximately $38.77 billion in 2026 and is projected to grow at an annual rate of roughly 10% through 2033, according to a market analysis from Grand View Research, with growth attributed to rising health awareness, an expanding middle class, and demand for preventive health products.²

That growth has drawn increased interest from ingredient suppliers and contract manufacturers looking to establish or expand a regional commercial presence.

What Should Manufacturers Take From This Announcement?

Saanroo describes the expansion in strategic terms, long-term growth, deepened market presence, closer customer relationships, without disclosing financial commitments, staffing levels, or measurable milestones tied to the India operation. That framing reflects the company's own characterization of its market position rather than independently verified data specific to Saanroo's business.

For manufacturers evaluating Saanroo as an ingredient supplier, the announcement is most useful as a signal of where the company is investing commercial infrastructure next, following a pattern that began with the October 2025 rebrand and continued through North American and Latin American expansion earlier this year. Chauhan's hire suggests a specific focus on customer-facing commercial support in India and the surrounding region rather than a change to the company's ingredient portfolio or clinical research pipeline. It is yet to be revealed how the India expansion will affect lead times, technical support, or pricing for existing customers.

References

1. Saanroo. Saanroo strengthens global organization through expanded operations in India & Southwest Asia. Press release provided via email. July 27, 2026. Accessed July 28, 2026.

2. Grand View Research. India nutraceuticals market (2026-2033). April 2026. Accessed July 28, 2026. https://www.grandviewresearch.com/industry-analysis/india-nutraceuticals-market-report